C4 Therapeutics, Inc. (CCCC) — 分析师展望 / 分析师共识目标价为. 基于 14 位分析师评级, 共识为 看涨 — 10 买入, 3 持有, 1 卖出.
分析师共识目标价为 $7.00, 上涨空间为 153.6% 相对于当前价格 $2.76.
分析师预估 每股收益(EPS)为 $-1.49 和 营收为 $0.04B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-1.52 vs 预期 $-1.49 (不及预期 -2%). 2025: 实际 $-1.27 vs 预期 $-1.41 (超预期 +9.7%). 分析师准确度: 94%.
CCCC 股票 — 12个月价格预测
$7.00
▲ +153.62% 上涨空间
平均目标价
Based on 14 Wall Street analysts offering 12-month price targets for C4 Therapeutics, Inc., the price target is $7.00.
平均目标价相对最新价格 $2.76 变动 +153.62%。
CCCC 分析师评级
Buy
基于过去3个月内 14 位分析师对 C4 Therapeutics, Inc. 的评级
EPS 预测 — CCCC
94%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$1.52
vs Est –$1.49
▼ 1.9% off
2025
Actual –$1.27
vs Est –$1.41
▲ 10.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — CCCC
92%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.036B
vs Est $0.036B
▼ 0.6% off
2025
Actual $0.036B
vs Est $0.030B
▲ 15.6% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
